Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Mortality after release from prison.

Coffin PO.

N Engl J Med. 2007 Apr 26;356(17):1785; author reply 1786-7. No abstract available.

PMID:
17465043
2.

An overview of heroin overdose prevention in the northeast: new opportunities.

Thurmond P, Bowman S.

Med Health R I. 2007 May;90(5):148-51. Review. No abstract available.

PMID:
17557658
3.

Mortality after release from prison.

Wines JD Jr, Saitz R, Samet JH.

N Engl J Med. 2007 Apr 26;356(17):1785-6; author reply 1786-7. No abstract available.

PMID:
17465044
4.
5.

Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison.

Bird SM, McAuley A, Perry S, Hunter C.

Addiction. 2016 May;111(5):883-91. doi: 10.1111/add.13265. Epub 2016 Feb 4.

6.

Overdose prevention: naloxone with long acting opioids.

Bowman S, McKenzie M, Rich J.

Med Health R I. 2008 Sep;91(9):271-2. No abstract available.

PMID:
18834043
7.

Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes.

Dettmer K, Saunders B, Strang J.

BMJ. 2001 Apr 14;322(7291):895-6. No abstract available.

8.

Preventing death among the recently incarcerated: an argument for naloxone prescription before release.

Wakeman SE, Bowman SE, McKenzie M, Jeronimo A, Rich JD.

J Addict Dis. 2009;28(2):124-9. doi: 10.1080/10550880902772423.

9.

Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: effective, but dissemination is challenging.

Mayet S, Manning V, Williams A, Loaring J, Strang J.

Int J Drug Policy. 2011 Jan;22(1):9-15. doi: 10.1016/j.drugpo.2010.09.008. Epub 2010 Nov 1.

PMID:
21044832
10.

Opioids and deaths.

Rich JD, Green TC, McKenzie MS.

N Engl J Med. 2011 Feb 17;364(7):686. doi: 10.1056/NEJMc1014490#SA1. No abstract available.

PMID:
21323559
11.

Overdose prevention for prisoners in New York: a novel program and collaboration.

Zucker H, Annucci AJ, Stancliff S, Catania H.

Harm Reduct J. 2015 Nov 5;12:51. doi: 10.1186/s12954-015-0084-8.

12.

Suicide risk among recently released prisoners in New South Wales, Australia.

Kariminia A, Law MG, Butler TG, Levy MH, Corben SP, Kaldor JM, Grant L.

Med J Aust. 2007 Oct 1;187(7):387-90.

PMID:
17908000
13.

Characterization of opioid overdose and response in a high-risk community corrections sample: a preliminary study.

Cropsey KL, Martin S, Clark CB, McCullumsmith CB, Lane PS, Hardy S, Hendricks PS, Redmond N.

J Opioid Manag. 2013 Nov-Dec;9(6):393-400. doi: 10.5055/jom.2013.0181.

PMID:
24481927
14.

Attacking overdose on the home front.

Darke S.

Addiction. 1999 Feb;94(2):205-6; discussion 207. No abstract available.

PMID:
10396786
15.

A project which deserves support.

Henry JA.

Addiction. 1999 Feb;94(2):206; discussion 207. No abstract available.

PMID:
10396787
16.

Naloxone use in a tiered-response emergency medical services system.

Belz D, Lieb J, Rea T, Eisenberg MS.

Prehosp Emerg Care. 2006 Oct-Dec;10(4):468-71.

PMID:
16997776
17.

Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City.

Heller DI, Stancliff S.

Public Health Rep. 2007 May-Jun;122(3):393-7. No abstract available.

18.

Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.

Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, Offor E, Semmler C.

Addiction. 2008 Oct;103(10):1648-57. doi: 10.1111/j.1360-0443.2008.02314.x.

PMID:
18821875
19.

Data on take home naloxone are unclear but not condemnatory.

Bigg D.

BMJ. 2002 Mar 16;324(7338):678. No abstract available.

20.

Acute drug-related mortality of people recently released from prisons.

Møller LF, Matic S, van den Bergh BJ, Moloney K, Hayton P, Gatherer A.

Public Health. 2010 Nov;124(11):637-9. doi: 10.1016/j.puhe.2010.08.012.

PMID:
20888607

Supplemental Content

Support Center